Joseph Edelman – PTGX history
- Issuer:
- PROTAGONIST THERAPEUTICS INC
- Quarters tracked:
- 6 (Q4 2024 → Q1 2026)
- Current shares:
- 1,230,879
- Current value:
- $129.74M
- Peak shares:
- 1,350,425 (Q4 2025)
- Overall change:
- -3%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 1,230,879 | $129.74M | $105.40 | -119,546 | -9% |
| Q4 2025 | 1,350,425 | $117.95M | $87.34 | +320,291 | +31% |
| Q3 2025 | 1,030,134 | $68.43M | $66.43 | -44,314 | -4% |
| Q2 2025 | 1,074,448 | $59.38M | $55.27 | -16,823 | -2% |
| Q1 2025 | 1,091,271 | $52.77M | $48.36 | -180,391 | -14% |
| Q4 2024 | 1,271,662 | $49.09M | $38.60 | — | NEW |